Exhibitors 2023



Biofilm Susceptibility Test (BeST).

Biofilm Susceptibility Test (BeST).

The Biofilm Susceptibility Test (BeST) is crucial in healthcare. It analyzes biofilm-forming bacteria, which have enhanced antibiotic resistance, leading to persistent, hard-to-treat infections. BeST not only tests classic antimicrobials but can also test new compounds supporting in the select of effective treatments, reducing recovery time and complications. It promotes appropriate antibiotic use, curtailing resistance development. BeST is essential for addressing medical device-related infections, often linked to biofilm bacteria, guiding a targeted therapeutic approach.


Biofilm Susceptibility Test (BeST).

E.G. Di Domenico, L. Toma, F. Ensoli

Enea G. Di Domenico is an assistant professor in Microbiology at Sapienza University in Rome. His research focuses on chronic biofilm-related infections, antibiotic resistance, and skin microbiota in dermatological diseases.
Luigi Toma is an infectious disease specialist at the Istituti Fisioterapici Ospitalieri (IFO) with over 20 years of experience in infectious diseases. He held various roles globally, including as a WHO Medical Consultant.
Fabrizio Ensoli, a distinguished virologist, worked at the National AIDS Center at ISS, focusing on HIV pathogenesis and AIDS vaccines. He was the head of the Microbiology and Virology laboratory at S. Gallicano Institute until 2021.


  C3 (pav. 6C.03)
Back
 
Data updated on 2024-07-22 - 12.15.47 pm